Leadership | Jazz Pharmaceuticals
https://www.jazzpharma.com/about/leadershipMr. Cozadd co-founded Jazz Pharmaceuticals, Inc. in 2003 and has served as our Chairman and Chief Executive Officer since April 2009. From 1991 until 2001, he held various positions with ALZA Corporation, a pharmaceutical company acquired by Johnson & Johnson, most recently as Executive Vice President and Chief Operating Officer, with responsibility for research and …
Jazz Pharmaceuticals - Wikipedia
https://en.wikipedia.org/wiki/Jazz_PharmaceuticalsJazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid(G…
Jazz Pharmaceuticals Careers
careers.jazzpharma.com › jobsJazz Pharmaceuticals will consider requests for reasonable accommodation to the extent required by law. Jobs. Europe & International. NA Commercial and Medical. Corporate. Tech Ops/Manufacturing. Research & Development. All Jobs. Benefits.
Improving Patients' Lives | Jazz Pharmaceuticals
https://www.jazzpharma.com13.12.2021 · Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor. December 13, 2021. PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of ...
Improving Patients' Lives | Jazz Pharmaceuticals
www.jazzpharma.comDec 13, 2021 · Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc See all News Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.
Jazz Pharmaceuticals - Wikipedia
en.wikipedia.org › wiki › Jazz_PharmaceuticalsJazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland.It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB).